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Abstract
Purpose: To gain insight into the accuracy of brachytherapy treatments, the accuracy of implant reconstruction and dose delivery was
investigated in 33 radiotherapy institutions in The Netherlands and Belgium.
Materials and methods: The accuracy of the implant reconstruction method was determined using a cubic phantom containing 25 spheres
at well-known positions. Reconstruction measurements were obtained on 41 brachytherapy localizers, 33 of which were simulators. The
reconstructed distances between the spheres were compared with the true distances. The accuracy of the dose delivery was determined for
high dose rate (HDR), pulsed dose rate (PDR) and low dose rate (LDR) afterloading systems using a polymethyl methacrylate cylindrical
phantom containing a NE 2571 ionization chamber in its centre. The institutions were asked to deliver a prescribed dose at the centre of the
phantom. The measured dose was compared with the prescribed dose.
Results: The average reconstruction accuracy was 20.07 mm (^0.4 mm, 1 SD) for 41 localizers. The average deviation of the measured
dose from the prescribed dose was 10.9% (^1.3%, 1 SD) for 21 HDR afterloading systems, 11.0% (^2.3%, 1 SD) for 12 PDR afterloaders,
and 11.8% (^2.5%, 1 SD) for 15 LDR afterloaders.
Conclusions: This comparison showed a good accuracy of brachytherapy implant reconstruction and dose delivery in The Netherlands and
Belgium. q 2001 Elsevier Science Ireland Ltd. All rights reserved.
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1. Introduction
Brachytherapy is performed in 39 different institutions in
The Netherlands and Belgium. The remote afterloading
equipment that is currently installed in these institutions is
shown in Table 1. Each institution has its own quality assur-
ance (QA) programme for checking the accuracy of relevant
physical parameters, guided by the many directives
published on this subject [3±5,7,8,11,12,14,21,25]. Because
of this, the test frequency, test methodology and accuracy
criterion of the QA tests differ signi®cantly between the
institutions.
A taskgroup on QA of brachytherapy systems of The
Netherlands Commission on Radiation Dosimetry (NCS)
has developed guidelines for QA in brachytherapy [17], in
the same way as was done before for medical accelerators
and simulators and computed tomography (CT) scanners
[15,16]. To achieve this goal, four stages have been distin-
guished by the task group.
1. Gain insight into the current practice of QA of
brachytherapy.
2. Determine the accuracy of implant reconstruction and
dose delivery in all institutions.
3. Compare the current QA practice with existing recom-
mendations on QA.
4. Formulate a set of minimum requirements on QA.
To gain insight into the current QA practice, an extensive
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questionnaire on the QA of brachytherapy systems was
completed by the radiotherapy institutions in The Nether-
lands and Belgium in 1998. The accuracy of the implant
reconstruction and dose delivery was determined by
performing on-site measurements with two dedicated phan-
toms in the institutions. The current QA practice and the
results of the on-site measurements were compared with
international QA recommendations. From this, a set of mini-
mum requirements on QA, suitable for the situation in The
Netherlands and Belgium, was formulated and published as
an NCS report [17].
The accuracy of a brachytherapy treatment depends on
many parameters, such as source activity, source position,
irradiation time, implant reconstruction and dose calculated
by the treatment planning software. In practice, an accuracy
of physical dose delivery of 5±10% is thought to be achiev-
able [12].
Clearly, source calibration is the physical parameter in
brachytherapy dose delivery that is most frequently studied
[1,2,18,20,23]. However, the dose delivery accuracy
depends on many physical parameters. Although a check
of the individual parameters is part of most QA
programmes, the delivered dose is generally not directly
determined. It was decided to gain more insight into the
accuracy of implant reconstruction and dose delivery in
brachytherapy. Therefore, on-site measurements with two
dedicated phantoms were performed in the institutions
using brachytherapy in The Netherlands and Belgium. The
methods and results are presented in this paper.
2. Materials and methods
2.1. Reconstruction measurements
To check the reconstruction methods used with
brachytherapy localizers, a cubic polymethyl methacrylate
(PMMA) phantom (further referred to as reconstruction
phantom) was used consisting of six identical 20 mm thick
slabs [3]. At each interface between the slabs, ®ve 2 mm
spheres are inserted (see Fig. 1). The positions of the spheres
are known with an accuracy of ^0.10 mm (1 SD).
The institutions were asked to reconstruct the phantom
using the equipment and procedures that are routinely used
for reconstruction of brachytherapy implants. For this
purpose, the phantom was positioned on the treatment
table with the central marker close to the isocentre of the
localizer, in the case of an isocentric localizer. For non-
isocentric localizers, a reconstruction box was used. The
co-ordinates of the spheres were determined by reconstruc-
tion from two X-ray ®lms, except for a CT-based recon-
struction. From these co-ordinates, 300 inter-sphere
distances were calculated, ranging from 20 to 140 mm,
with an average of 66 mm. The reconstructed distances
were compared with the true distances leading to an average
deviation of the 300 inter-sphere distances. In this way, the
®nal result re¯ects the geometrical accuracy of the localizer,
the digitizer and the reconstruction algorithm.
Reconstruction of brachytherapy implants is commonly
performed on a simulator (29 institutions). Some institutions
have more than one localizer available for brachytherapy
implant reconstruction. The reconstruction measurements
were performed on 41 localizers (33 simulators, ®ve C-
arms, one mobile X-ray unit, one integrated brachytherapy
unit localizer and one CT scanner) in 33 institutions. The
magni®cation factor used as input in case of isocentric loca-
lization varied between 1.35 and 1.55. Orthogonal recon-
struction was used on all simulators, except for one case,
where a variable angle reconstruction was applied using
gantry angles of 2308 and 1308.
2.2. Dose measurements
To determine the accuracy of the dose delivery in the
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Table 1
Remote afterloading high dose rate (HDR), pulsed dose rate (PDR), and
low dose rate (LDR) systems installed in The Netherlands and Belgium
Brachytherapy Afterloading system Source(s) No. of installed
systems
HDR Nucletrona microSelectron 192Ir 17
HDR Sauerweinb Gammamed 192Ir 3
HDR Varianc Varisource 192Ir 1
PDR Nucletron microSelectron 192Ir 12
PDR Sauerwein Gammamed 192Ir 3
LDR Nucletron Selectron 137Cs 16
LDR Nucletron microSelectron 192Ir/137Cs 13
LDR Arplayd Telegyn 137Cs 1
LDR CIS bioe Curietron 137Cs 2
a Nucletron B.V., The Netherlands.
b Isotopen-Technik Dr. Sauerwein GmbH, Germany.
c Varian Medical Systems, Inc., USA.
d Arplay Medical, France.
e CIS bio International, France.
Fig. 1. The geometry of the reconstruction phantom. The phantom contains
25 spheres at well-known positions, from which 300 inter-sphere distances
can be calculated, varying between 20 and 140 mm.
institutions, a solid phantom (further referred to as dose
phantom) was used, as designed by Meertens [10]. The
phantom is a PMMA cylinder with a diameter of 20.0 cm
and a height of 15.0 cm. An NE 2571 (Nuclear Enterprises
Ltd, UK) ionization chamber is positioned centrally in the
phantom and three brachytherapy applicators are placed at
5.0 cm from the ionization chamber, equally spaced at 1208
angles (see Fig. 2). The dose delivered during the treatment
is measured by the ionization chamber surrounded by its
build-up cap, in combination with a Precitron (Precitron
AB, Sweden) Janus electrometer. The chamber was cali-
brated in combination with the electrometer in September
1998 at The Netherlands Measurements Institute, the
National Standards Laboratory for Ionizing Radiation.
2.2.1. Measurement procedure
The institutions were asked to prepare a treatment plan to
deliver a prescribed dose in the centre of the ionization
chamber using ®xed source positions. The source positions
used during the measurements are based on the source cali-
bration protocols for 192Ir HDR sources [14] and 137Cs
pellets [13] for this phantom. For HDR and PDR afterloa-
ders, one source position per catheter is used in the same
plane as the effective point of measurement (the centre of
the ionization chamber). For Selectron LDR afterloaders,
six sources per catheter are used, three on both sides of
the central plane of the phantom at distances of 17.5, 20.0
and 22.5 mm from that plane (Fig. 3).
Because the reconstruction accuracy is measured sepa-
rately, the source positions are entered in the treatment plan-
ning system (TPS) using co-ordinates and not by
reconstruction of the phantom. In this way, the error in
dose delivery caused by an error in reconstruction of the
set-up is avoided. However, in some TPSs, source position
co-ordinates cannot be entered directly. In the two institu-
tions using such a TPS, the geometry was reconstructed
from a drawing of the experimental set-up as accurately as
possible.
The value for the prescribed dose was determined as a
compromise between the accuracy of the electrometer and
practical considerations, such as the required measuring
time. A prescribed dose of 75 cGy for HDR, 40 cGy for
PDR, and 20 cGy for LDR afterloaders was used. These
doses resulted in treatment times (depending on the exact
source strength) of approximately 5 min for a 2 cGym2/h
HDR 192Ir source, 25 min for a 0.22 cGym2/h 192Ir PDR
source, and 45 min for 18 137Cs LDR sources with a source
strength of 0.004 cGym2/h.
After installation of the phantom, air temperature and
pressure were recorded. The dose delivery measurement is
performed three times, using the dwell times calculated by
the TPS. The measurement is performed with plastic cathe-
ters or needles, corresponding to the normal use for treat-
ments in the institution.
2.2.2. Conversion of electrometer readings to dose in water
The electrometer reading is converted to a dose to water
value using the equation [14]:
Dw  MNKPkiPpiPfiSd mr
 water
air
1 2 g 1
where M  Muncorrptppphumpionppol, Ppi prpce, Pki
kwkstkce, and Pfi  f trf phf geof cath.
The meaning and value of these factors are described in
Table 2. Most of these factors were determined in previous
studies [10,13,14,22]. The air kerma calibration factor for
192Ir and 137Cs of the ionization chamber with build-up cap
in combination with the electrometer was derived from NK
factors obtained during calibration at the National Standards
Laboratory. Values for the mass-energy absorption coef®-
cient m=rwaterair for 192Ir and 137Cs were taken from the litera-
ture [4,19]. In TPSs, either the value 1.10 or 1.11 is used.
Here, the value 1.11 was used in the calculations. The in¯u-
ence of the transit dose ( ftr) and the applicator attenuation
( fcath) had to be determined separately and will be discussed
in the next paragraphs.
2.2.3. Determination of the transit dose correction factor
The clinical treatment planning generally neglects the
transit dose, i.e. the dose delivered during transport of the
source from the afterloader to the patient. The transit dose
depends on the source strength, the velocity of the source
transport and the geometry of the set-up. To compare the
dose measured in the phantom with the dose calculated by
the planning system, and to compare measurements in
different institutions, the measured dose was corrected for
the transit dose using the factor ftr [14]. For a ®xed geome-
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Fig. 2. Cylindrical dose phantom. Three applicators are positioned at 5.0 cm
from the centrally placed ionization chamber.
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Fig. 3. The dose distribution for the cylindrical dose phantom (a) for HDR/PDR and Selectron LDR afterloaders in three orthogonal planes passing through the
effective measurement point of the ionization chamber (b).
try, such as the dose phantom, the value for this factor can
be derived from:
ftr  1 2 Mt0
Mt
2
where t is the dwell time, Mt0 is the electrometer reading at
t  0 (zero dwell time, only dose contribution during source
transport) and Mt is the electrometer reading for dwell time
t. The value for t  0, Mt0, is determined for the speci®c
geometry by programming dwell times in the range of 5±
120 s per channel and by linear extrapolation of the
measured doses to t  0. Since the transit dose linearly
depends on the source strength, and experience has shown
that the source transport velocities on identical machines are
comparable, its value for identical machines in different
institutions can be calculated from the value measured on
a single afterloader with reasonable accuracy.
2.2.4. Attenuation in the applicator wall
To determine the difference in attenuation between plas-
tic catheters and metal needles during HDR/PDR measure-
ments, a correction factor fcath was determined. The value for
fcath was determined as the ratio of the reading obtained
when using plastic catheters and the reading obtained
when using needles, and was found to be 1.009 (^0.003,
1 SD). To compare the dose measured in the phantom with
the dose calculated by the TPS, and to compare measure-
ments in different institutions, the measured dose was
corrected for the attenuation in institutions where needles
were used during the measurements.
For the Selectron LDR afterloader, the factor fcath for the
replacement of water-equivalent catheters by the stainless
steel standard catheters is included in the factor fph [10].
2.3. Source positioning accuracy for HDR and PDR
afterloaders
In the solid phantom dose delivery measurements, the
combined accuracy of source calibration, source position-
ing, timer and dose calculation of the treatment planning
software is determined. An error in source calibration,
timer or dose calculation will in¯uence the measured dose
proportionally. For example, an error in source calibration
of 2% will be measured as an error in the delivered dose of
2%. However, an error in source positioning along the
catheter will hardly in¯uence the measured dose. This is
caused by the relatively uniform dose distribution around
the ionization chamber, which is the result of the applied
source con®guration. To illustrate this, the electrometer
reading is plotted as a function of the source position
along a single catheter for a HDR unit in Fig. 4. The maxi-
mum reading is obtained at z  0 mm, when the source is
opposite to the ionization chamber. An error of 2 mm in the
source position around this optimum will result in a devia-
tion in the measured dose of only 0.2% (Fig. 4).
In clinical treatments, however, a systematic error in
R.J.M. Elfrink et al. / Radiotherapy and Oncology 59 (2001) 297±306 301
Table 2
Factors for conversion of the electrometer reading to dose in water for 192Ir and 137Cs sources measured in the PMMA cylindrical phantom (see also Refs.
[10,13,14,22])
Factor Description Value for 192Ir in the phantom Value for 137Cs in the phantom
Muncorr Uncorrected instrument reading
pt Temperature correction factor (Tmeas 1 273.15/Tcalibration) (Tmeas 1 273.15/Tcalibration)
pp Air pressure correction factor (pcalibration/pmeas) (pcalibration/pmeas)
phum Humidity correction factor 1.000 1.000
pion Ion recombination correction factor 1.000 1.000
ppol Correction factor for polarity effects 1.000 1.000
NK Air kerma calibration factor From calibration From calibration
pr Correction factor for replacement of PMMA by the ionization
chamber
1.016 0.997
pce Correction factor for the effect of the central electrode during the
measurement
1.000 1.000
kw Correction factor for attenuation and scatter in the chamber wall 0.984 0.9904
kst Correction factor for the stem effect during calibration 1.000 1.000
kce Correction factor for the effect of the central electrode during
calibration
1.000 1.000
ftr Correction factor for source transport time Variable 1.000
fph Conversion factor from the speci®ed PMMA phantom to a full-
scatter water phantom
1.033 1.041
fgeo Correction factor for absorption and scatter in water 1/S(d) 1/S(d)
fcath Correction factor for attenuation in plastic catheter/needles 1.000/1.009 Included in fph
S(d) Correction factor for scattering and absorption in the phantom
material
See Refs. [10,13,14,22] See Refs. [10,13,14,22]
m=rwaterair Mass-energy absorption coef®cient 1.11 1.11
g Fraction of kinetic energy of secondary particles converted to
bremsstrahlung
0.000 0.003
source positioning of 2 mm for the entire implant can result
in a signi®cant error in dose delivery because of the possible
geometrical miss of the target volume. It would therefore be
useful to also obtain information on the source positioning
accuracy. Because the effect of source positioning on the
electrometer reading is much larger on the slopes of the
curve, it was decided for HDR and PDR afterloaders to
use two extra measurements at positions 120 and 220
mm from the optimum source position (z  0 mm). The
difference in electrometer reading between a source at
120 mm and a source at 220 mm is used to calculate the
error in the source position. For example, if in an institution
an error in source positioning of 2 mm exists, the source is
positioned at z  12 mm for the measurements; the differ-
ence in electrometer reading between source position z 
218 mm and z  122 mm is then approximately 6% (Fig.
4), which can easily be measured. For Cs LDR afterloaders,
a systematic error in source positioning is less probable
because of the ®xed source positions. This extra measure-
ment was therefore not performed for the LDR afterloaders.
3. Results
3.1. Reconstruction measurements
The results of the measurements with the reconstruction
phantom for the 41 localizers are shown in Fig. 5 as the
average reconstruction error of 300 reconstructed distances.
The deviation of the reconstructed distances was smaller
than 0.5 mm for 36 localizers, and even smaller than 0.25
mm for 27 localizers. For one C-arm, the error was 22.1
mm, and for another C-arm (with reconstruction box) the
deviation was 11.3 mm. For the 41 localizers, an average
deviation of 0.1 mm (^0.5 mm, 1 SD) was found.
3.2. Dose measurements
3.2.1. Transit dose correction factor
The transit dose correction factor for the speci®c phantom
has been determined for microSelectron HDR and PDR
afterloaders (Nucletron, The Netherlands) by measuring
the electrometer reading with the source position opposite
to the ionization chamber at different dwell times (see Fig.
6). The measurements are repeated for four afterloaders.
The y-axis cut-off of these curves determines the transit
dose delivered, which is expected to vary linearly with
source strength. The axis cut-off is converted into dose
units and is plotted as a function of the source strength in
Fig. 7. The measurements were performed on two HDR and
two PDR afterloaders. Since the transit dose linearly
depends on the source strength, and because the source
transport velocity on identical machines is comparable, its
value for identical machines in different institutions was
calculated from the value measured on the four afterloaders.
For non-Nucletron machines, the transit dose was deter-
mined on each individual machine using the described
method.
As can be seen from this ®gure, the transit dose amounts
for this speci®c experimental set-up (i.e. measurements in
the solid phantom with the source positioned at 5.0 cm from
the applicators and a dwell time range of 0±120 s on Nucle-
R.J.M. Elfrink et al. / Radiotherapy and Oncology 59 (2001) 297±306302
Fig. 4. Electrometer reading as a function of the source position along the
catheter (z-direction) in the dose phantom (for the geometry see Fig. 3). The
maximum reading is obtained at z  0 mm, when the source is opposite to
the ionization chamber. The difference in reading between z  220 mm
and z  120 mm is used to estimate the error in source positioning.
Fig. 5. Results of the reconstruction accuracy measurements on 41
brachytherapy localizers: average deviation of 300 reconstructed distances
(ranging from 20 to 140 mm) from the true distances between 25 spheres in
the reconstruction phantom. A positive deviation indicates a reconstructed
distance larger than the true distance.
Fig. 6. Determination of the transit dose for microSelectron HDR and PDR
afterloaders in four different institutions. The electrometer reading is
measured for dwell times varying from 5 to 120 s. The y-axis cut-off
represents the transit dose for this speci®c experimental set-up.
tron afterloaders) were approximately 0.4 cGy for a 4
cGym2/h HDR source and 0.04 cGy for a 0.4 cGym2/h
PDR source. Relative to the prescribed dose of 75 cGy for
HDR and 40 cGy for PDR afterloaders, the maximum
contribution of the transit dose to the measured dose is
0.5% for HDR and 0.1% for PDR afterloaders. For LDR
afterloaders the relative contribution of the transit dose to
the prescribed dose has not been determined, but will be
lower than for the PDR afterloaders because of the longer
measuring times. The measured doses on HDR afterloaders
were corrected according to Fig. 7. For PDR and LDR after-
loaders, the effect of the transit dose was neglected.
3.2.2. Dose measurements
Dose measurements were performed on 21 HDR after-
loaders, 12 PDR afterloaders and 15 LDR afterloaders. The
results of the dose measurements are summarized in Fig. 8.
In the histogram, the percentage difference is shown
between the measured dose and the prescribed dose. For
the 21 HDR afterloaders, an average deviation of 10.9%
(^1.3%, 1 SD) was measured, with two afterloaders having
a deviation of more than 2%. For the 12 PDR afterloaders,
the average deviation was 11.0% (^2.3%, 1 SD), with ®ve
afterloaders having a deviation of more than 2%. For
measurements on 15 Selectron LDR afterloaders, an aver-
age deviation of 11.8% (^2.5%, 1 SD) was found, with ®ve
afterloaders having a deviation of more than 2% and a range
of 23.3 to 16.8%.
3.3. Source positioning accuracy
The accuracy of the source positioning was measured for
HDR and PDR afterloaders by the method described in
Section 2.3. The average error on source positioning was
measured on 16 HDR afterloaders and was found to be 0.2
mm (^1.0 mm, 1 SD). In three institutions, a deviation
larger than 1 mm was observed, with a maximum deviation
of 2.3 mm. For 11 PDR afterloaders, the average error in
source positioning was 0.2 mm (^1.1 mm, 1 SD), with four
institutions having deviations larger than 1 mm, and a maxi-
mum deviation of 2.0 mm.
4. Discussion
4.1. Reconstruction measurements
The results of the reconstruction measurements (Fig. 5)
re¯ect the geometrical accuracy of the localizer, the digiti-
zer and the reconstruction algorithm. For two C-arms, an
average deviation of larger than 1 mm was observed. The
reason for this deviation can be found when plotting the
deviation of each reconstructed distance for this C-arm as
a function of the reconstructed distance (Fig. 9). For
comparison a similar graph is shown for a simulator with
a very small average deviation.
As can be seen from Fig. 9, the deviation of the recon-
structed distance increases with the distance between the
spheres for the C-arm, whereas for the simulator there is
no correlation between deviation and distance. This shows
that the deviation for the C-arm is most likely caused by an
incorrect magni®cation factor of the localizer.
In a comparison of computer planning systems performed
in 1987, Visser [24] found deviations of up to 5 mm when
reconstructing gynaecological applicators from orthogonal
radiographs, leading to discrepancies of 10% in the dose
rate. Kolkman-Deurloo et al. [9] found an average recon-
struction error of 0.04 mm for a dedicated brachytherapy
localizer using a similar phantom and orthogonal recon-
struction. This value increased to 0.4 mm when reconstruct-
ing from ¯uoroscopy images instead of using ®lm. It was
found that these deviations did not in¯uence the treatment
time when considering clinical implant geometries.
The results in the present work indicate that the recon-
struction accuracy errors in The Netherlands and Belgium
are comparable to those found by Kolkman-Deurloo et al.
[9] and that these errors will have only a minor effect on the
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Fig. 7. Results of measurements of the transit dose for the experimental set-
up in different institutions as a function of the source strength for micro-
Selectron HDR and PDR afterloaders.
Fig. 8. Results of dose delivery measurements on 21 HDR, 12 PDR and 15
LDR afterloaders in The Netherlands and Belgium: percentage difference
between the measured dose in the phantom and the prescribed dose in the
planning system. The average deviation is 10.9% for HDR, 11.0% for
PDR, and 11.8% for LDR afterloaders. All results were within a range of
23.3 to 16.8%.
overall treatment time. The reconstruction accuracy has
improved enormously since the 1987 investigation of Visser
[24]. Based on the results of these measurements, the task
group recommends an annual check of the reconstruction
accuracy by reconstruction of a phantom with a well-known
geometry. It is emphasized that the reconstruction error
measured in this work represents the physical error in an
ideal situation. In practice, the error can be larger due to, for
example, patient movement.
4.2. Dose measurements
The difference between the measured dose and the
prescribed dose is the result of the sum of errors in source
calibration, dose calculation of the TPS, source positioning
and irradiation timer.
Clearly, source activity is one of the most important
physical parameters in brachytherapy dose delivery. In a
comparison of source calibration procedures for 192Ir HDR
sources in The Netherlands and Belgium performed in 1992,
Venselaar et al. [23] found deviations from the certi®cate's
value of up to 6.8%. Baltas et al. [2] reported deviations
from the certi®cate in the range of 213.0 to 16.0% for 192Ir
HDR sources. In a recent comparison of calibration proce-
dures for 192Ir HDR sources in Brazil, de Almeida et al. [1]
found deviations in the range of 24.6 to 12.4%.
For 137Cs LDR sources, Meertens [10] found deviations
from the source strength certi®cate in the range of 22.3 to
13.9% in nine institutions.
It is recommended by the NCS that the user of 192Ir after-
loading equipment performs his own calibration for each
new source [14]. In the current investigation, it was found
that the strength of each 192Ir HDR source is independently
determined in 20 out of 21 institutions using HDR and in all
institutions using PDR, mostly using the in-air method with
a calibration jig. In one institution, the calibration of the
source is not yet performed, but is planned for the near
future. The current practice of in-house source calibration
in The Netherlands and Belgium was investigated by means
of a questionnaire on the QA of brachytherapy and is
summarized in Table 3.
Apart from source calibration, the dose calculation by the
TPS is expected to be a signi®cant cause of deviations in the
measured dose. For example, Feroldi et al. [6] showed in a
comparison of TPSs that dose rate errors larger than 5% may
occur. To investigate the effect of the different TPSs on the
total treatment time, the treatment time as calculated by the
TPS in each institution for the speci®c experimental set-up
and prescribed dose was normalized to a ®xed source
strength. The treatment time calculated by the TPS of an
institution is then compared with the average normalized
treatment time of all institutions. For HDR and PDR
brachytherapy the normalized treatment times for the differ-
ent TPSs varied between 20.7 and 11.3% around the aver-
age calculated treatment time. For TPSs in use for Selectron
LDR brachytherapy, the effect of the TPS on the measured
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Fig. 9. Absolute value of the reconstruction deviation as a function of the
reconstructed distance for a C-arm with an average deviation of 2.09 mm
(a) and a simulator with an average deviation of 0.03 mm (b). The line
shows that the deviation increases with reconstructed distance for the C-
arm, while this is not the case for the simulator.
Table 3
Source calibration practice of HDR, PDR and LDR brachytherapy in The Netherlands and Belgiuma
In-house calibration method Value in TPS
In-air In-phantom Well chamber No calibration In-house measured Certi®cate
HDR 15 2 3 1 14 7
PDR 11 1 ± ± 8 4
Cs LDR 2 7 4 2 5 10
a The number of institutions performing an in-house calibration method as well as the type of calibration method are listed. Furthermore, it is listed whether
the in-house measured source activity value or the value from the certi®cate is used in the TPS. The different methods available for in-house calibration of
brachytherapy sources are described in Refs. [10,13,14].
dose was larger: the calculated treatment times ranged from
22.9 to 13.7% around the average time. The effect of
applicator attenuation is ignored in most TPSs. The use of
needles instead of plastic catheters results in an attenuation
of approximately 0.9%. The effect of the TPS on the
measured dose is thus found to be small (,2%) for TPSs
in use for HDR and PDR brachytherapy and larger (up to
4%) for TPSs in use for LDR brachytherapy.
In our study, for one PDR afterloader, a deviation in dose
of 15.0% was measured. The reason for this deviation was
found to be an error in source positioning within the cali-
bration jig. After repair of the jig, the deviation was reduced
to 12.4%. For one Cs LDR afterloader, a deviation in dose
of 16.8% was measured. Repeating the dose measurement
several weeks later con®rmed the initial measurement. The
reason for the deviation is most probably an error in the
source strength value as speci®ed on the certi®cate of the
manufacturer. This was never checked independently and
was used in the TPS.
It should be emphasized that the measured values repre-
sent the physical accuracy of the treatment. In practice, one
should keep in mind that these ideal conditions are not
always ful®lled due to, for example, patient movement
and the lack of full scatter conditions. Therefore, the accu-
racy of the dose delivered to a patient will be lower.
4.3. Source positioning accuracy
Because of the high dose gradient near brachytherapy
sources, accurate source positioning is required to obtain
accurate dose delivery. In international reports, tolerance
levels of 1 mm [12,25] or 2 mm [7,17] are recommended.
The results of source positioning measurements on 16 HDR
and 11 PDR afterloaders showed that seven institutions had
a deviation in source positioning larger than 1 mm. Three of
these exceeded the recommended tolerance level of 2 mm.
4.4. Uncertainties
Uncertainties are distinguished as random (type A) and
systematic (type B) uncertainties. Type A uncertainties are
caused by small deviations in the readings of the electro-
meter, in the reading of the air pressure and temperature and
statistical deviations in the distance between the source and
ionization chamber. Since the inner diameter of the (Nucle-
tron) catheters is 1.8 mm and the outer diameter of the 192Ir
source is 1.1 mm, there is always an uncertainty in the
position of the source within the applicator in the radial
direction, with a maximum margin of 0.35 mm. At a 5.0
cm distance from the ionization chamber, this can result in
an error of ^1.4% in the measured dose, when using a
single catheter. In practice, differences as large as 1.4%
were observed when comparing the readings from the
three different channels of the phantom. However, the repro-
ducibility of the electrometer reading from all three chan-
nels was found to be better than 0.3%, so the overall effect
of the radial source positioning error on the electrometer
reading is small. The random error in the reading of the
barometer and thermometer is estimated to be 0.2%.
Type B uncertainties are determined by the uncertainties
in the physical quantities as given in Eq. (1) and Table 1.
The largest contribution is expected from the uncertainty of
the NK value (0.7%) and from the uncertainty in the replace-
ment factor pr (1.0%, see Ref. [22]). The uncertainties in the
other parameters are shown in Table 4. The estimated
combined uncertainty resulting from type A and type B
uncertainties for the dose measurements is 1.5%.
5. Conclusions
The accuracy of the reconstruction method and the dose
delivery in HDR, PDR and LDR brachytherapy was deter-
mined in 33 institutions in The Netherlands and Belgium.
The accuracy of the reconstruction method was deter-
mined using a cubic PMMA phantom containing 25 spheres
at well-known positions. The reconstruction accuracy was
found to be smaller than 0.5 mm for 36 of 41 localizers. For
two localizers, a deviation larger than 1.0 mm was observed,
which is most probably caused by an error in the magni®ca-
tion factor applied in the TPS.
The dose delivery accuracy was measured using a cylind-
rical PMMA phantom containing a NE 2571 ionization
chamber and three applicators at 5.0 cm from the ionization
chamber. The accuracy of the dose delivery was found to be
10.9% (^1.3%, 1 SD) for 21 HDR afterloaders, 11.0%
(^2.3%, 1 SD) for 12 PDR afterloaders, and 11.8%
(^2.5%, 1 SD) for 15 Selectron LDR afterloaders. For
one PDR afterloader, a deviation in dose of 15.0% was
measured. The cause for this deviation was a problem
with source positioning within the calibration jig. For one
Cs LDR afterloader, a deviation in dose of 16.8% was
measured. The cause for the deviation is most probably an
error in the source strength value on the certi®cate of the
manufacturer.
The results of the measurements showed that an accuracy
of physical dose delivery better than 5% was achieved in all
but one institution.
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Table 4
Estimated uncertainties, expressed as one standard deviation, resulting from
type A (statistical) and type B (systematical) uncertainties for the dose
measurements in the cylindrical phantoma
Parameter Uncertainty
type A (%)
Parameter Uncertainty
type B (%)
Muncorr 0.3 NK 0.7
pmeas 0.2 pr 1.0
Tmeas 0.2 fph 0.3
m=rwaterair 0.3
phum, pion, ppol, pce, kst, kce , 0.1
fcath 0.3
ftr 0.3
a For an explanation of the parameters, see Table 2.
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